JACKSONVILLE, Fla., March 15 (HSMN NewsFeed) — Ranbaxy Laboratories Limited, along with its wholly owned subsidiary Ranbaxy Pharmaceuticals Inc. (collectively, "Ranbaxy"), announced today that they have reached an agreement with Takeda Pharmac…
Biopharmaceuticals, Generics, Litigation
Ranbaxy Laboratories, Takeda Pharma, Actos, Pioglitazone

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation”
Leave a Comment